Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
462
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Thematic (Sector/Industry)
•
28 Feb 2017 17:16
Korea Stock Market Monthly Recap #11 - (February 2017)
Food for Thought - Is the major underperformance of semiconductor related stocks in Korea in February a short term blip or start of a major...
Douglas Kim
Follow
180 Views
Share
bullish
•
Samsung Biologics
•
05 Feb 2017 16:08
Revisiting Samsung BioLogics at This Interesting Time
I don't really intend to make any investment recommendation on BioLogics at this point. I have to admit that I'm still feeling the current price is...
Sanghyun Park
Follow
242 Views
Share
bullish
•
Thematic (Sector/Industry)
•
31 Jan 2017 22:29
Korea Stock Market Monthly Recap #10 - (January 2017)
The Trump economic hope continued to positively impact emerging markets, including Korea. KOSPI was up 2% in January 2017, versus our model...
Douglas Kim
Follow
318 Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Jan 2017 09:45
Whale Watching in the Korea Stock Market
There is an adage in the financial market that says, "Don't fight the FED." In the Korea Stock Market, there is an adage that says, "Don't fight...
Douglas Kim
Follow
245 Views
Share
bearish
•
Celltrion Inc
•
20 Jan 2017 20:59
Recent Developments Not Encouraging
This Insight provides an update on developments in the US market related to biosimilars, and are of great significance to Celltrion Inc (068270...
Kemp Dolliver, CFA
151 Views
Share
First
Previous
78
79
80
81
82
83
84
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x